Eight Cycles of BEACOPP Escalated Compared with 4 Cycles of BEACOPP Escalated Followed by 4 Cycles of BEACOPP Baseline with Our without Radiotherapy in Patients in Advanced Stage Hodgkin Lymphoma (HL): Final Analysis of the Randomised HD12 Trial of the German Hodgkin Study Group (GHSG)

被引：0
|
作者：
Diehl, Volker
Haverkamp, Heinz [1 ]
Mueller, Rolf Peter [2 ]
Eich, Hans Theodor [2 ]
Mueller-Hermelink, Hans Konrad [3 ]
Cerny, Thomas [4 ]
Markova, Jana [5 ]
Ho, Anthony [6 ]
Kanz, Lothar [7 ]
Greil, Richard [8 ]
Hiddemann, Wolfgang [9 ]
Engert, Andreas [2 ]
机构：
[1] Univ Cologne, Dept Internal Med 1, GHSG, Cologne, Germany
[2] Univ Cologne, Dept Radiotherapy, Cologne, Germany
[3] Univ Wurzburg, Dept Pathol, Wurzburg, Germany
[4] Kanionsspital St Gallen, Dept Oncol, St Gallen, Switzerland
[5] Fak Nemocnice, Clin Hematol, Prague, Czech Republic
[6] Univ Heidelberg, Dept Hematol & Oncol, Heidelberg, Germany
[7] Univ Tubingen, D-72074 Tubingen, Germany
[8] Salzburg Univ, Dept Internal Med 3, A-5020 Salzburg, Austria
[9] Univ Munic, Dept Internal Med 3, Munic, Germany
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：552 / 553
页数：2
相关论文
共 50 条
  • [31] 8X BEACOPPESC COMPARED TO 4X BEACOPPESC FOLLOWED BY 4X BEACOPPBASE WITH OUR WITHOUT RADIOTHERAPY FOR ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS: FINAL ANALYSIS OF THE HD12 TRIAL OF THE GERMAN HODGKIN STUDY GROUP
    Borchmann, P.
    Haverkamp, H.
    Mueller, R. -P.
    Eich, H. -T
    Mueller-Hermelink, H. K.
    Cerny, T.
    Markova, J.
    Ho, A. D.
    Kanz, L.
    Greil, R.
    Hiddemann, W.
    Engert, A.
    Diehl, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 437 - 437
  • [32] Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
    Engert, Andreas
    Diehl, Volker
    Franklin, Jeremy
    Lohri, Andreas
    Doerken, Bernd
    Ludwig, Wolf-Dieter
    Koch, Peter
    Haenel, Mathias
    Pfreundschuh, Michael
    Wilhelm, Martin
    Truemper, Lorenz
    Aulitzky, Walter-Erich
    Bentz, Martin
    Rummel, Mathias
    Sezer, Orhan
    Mueller-Hermelink, Hans-Konrad
    Hasenclever, Dirk
    Loeffler, Markus
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4548 - 4554
  • [33] Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles
    Dlugosz-Danecka, Monika
    Szmit, Sebastian
    Kocurek, Anna
    Kozlik, Pawel
    Giza, Agnieszka
    Zimowska-Curylo, Dagmara
    Malkowski, Bogdan
    Sowa-Staszczak, Anna
    Kuzdzal, Jaroslaw
    Jurczak, Wojciech
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (04): : 259 - 266
  • [34] PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study
    Eichenauer, D. A.
    Kreissl, S.
    Buehnen, I.
    Baues, C.
    Kobe, C.
    van Heek, L.
    Goergen, H.
    Fuchs, M.
    Hartmann, S.
    von Tresckow, B.
    Engert, A.
    Borchmann, P.
    ANNALS OF ONCOLOGY, 2021, 32 (06) : 807 - 810
  • [35] BEACOPP chemotherapy with dose escalation in advanced Hodgkin's disease: Final analysis of the German Hodgkin lymphoma study group HD9 randomized trial.
    Diehl, V
    Franklin, J
    Paulus, U
    Engert, A
    Wolf, J
    Hasenclever, D
    Duehmke, E
    Georgii, A
    Mueller-Hermelink, HK
    Loeffler, M
    BLOOD, 2001, 98 (11) : 769A - 769A
  • [36] Is an additive Radiotherapy for Patients in advanced Stages of a necessary Hodgkin's Lymphoma? - Final analysis of the HD12 trial of the German Hodgkin Study Group
    Kriz, J.
    Borchmann, P.
    Haverkamp, H.
    Diehl, V
    Mueller, R. -P
    Engert, A.
    Eich, H. -T
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 30 - 30
  • [37] BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group
    Diehl, V
    Franklin, J
    Hasenclever, D
    Tesch, H
    Pfreundschuh, M
    Lathan, B
    Paulus, U
    Sieber, M
    Rueffer, JU
    Sextro, M
    Engert, A
    Wolf, J
    Hermann, R
    Holmer, L
    Stappert-Jahn, U
    Winnerlein-Trump, E
    Wulf, G
    Krause, S
    Glunz, A
    von Kalle, K
    Bischoff, H
    Haedicke, C
    Duehmke, E
    Georgii, A
    Loeffler, M
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3810 - 3821
  • [38] EARLY CHEMOTHERAPY INTENSIFICATION WITH ESCALATED BEACOPP IN ADVANCED-STAGE HODGKIN LYMPHOMA WITH A POSITIVE INTERIM PET-CT AFTER 2 ABVD CYCLES: LONG-TERM RESULTS OF THE GITIL/FIL HD 0607 TRIAL
    Gallamini, A.
    Rossi, A.
    Patti, K.
    Picardi, M.
    Romano, A.
    Cantonetti, M.
    La Nasa, G.
    Trentin, L.
    Bolis, S.
    Rapezzi, D.
    Viviani, S.
    Gianni, A. M.
    Zoli, V.
    Gottardi, D.
    Tarella, C.
    Gavarotti, P.
    Corradini, P.
    Cimminiello, M.
    Schiavotto, C.
    Parvis, G.
    Zanotti, R.
    Gini, G.
    Ferreri, A. J.
    Viero, P.
    Miglino, M.
    Billio, A.
    Avigdor, A.
    Prosperini, G.
    Bergesio, F.
    Pavoni, C.
    Rambaldi, A.
    HAEMATOLOGICA, 2017, 102 : 145 - 146
  • [39] A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)
    Ballova, V
    Rüffer, JU
    Haverkamp, H
    Pfistner, B
    Müller-Hermelink, HK
    Dühmke, E
    Worst, P
    Wilhelmy, M
    Naumann, R
    Hentrich, M
    Eich, HT
    Josting, A
    Löffler, M
    Diehl, V
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 124 - 131
  • [40] Response-adapted therapy using FDG-PET after BEACOPP-chemotherapy in advanced stage Hodgkin's lymphoma - An interim analysis of the German Hodgkin Study Group (GHSG) trial HD15
    Eich, H. T.
    Kobe, C.
    Dietlein, M.
    Engert, A.
    Kriz, J.
    Mueller, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S471 - S471
12345